About University Hospital Duesseldorf

University Hospital Duesseldorf is a leading academic medical center in Germany, providing advanced diagnostics, innovative therapies, and comprehensive patient care. As part of Heinrich Heine University Duesseldorf, it combines clinical excellence, research-driven medicine, and medical education at the highest international standards.

Located in western Germany, the hospital is internationally recognized for its expertise in complex diseases, minimally invasive treatments, and interdisciplinary care models for national and international patients.

Comprehensive Medical Services

• Stem Cell Apheresis: University Hospital Duesseldorf offers peripheral blood stem cell apheresis within its hematology and transplantation programs. After mobilization therapy with G-CSF, stem cells are released into the bloodstream and selectively collected using modern cell separation systems.
  The procedure is performed under continuous medical supervision with sterile, single-use tubing systems, ensuring maximum safety. Apheresis typically lasts 3–5 hours in a comfortable clinical setting. The center performs approximately 350 stem cell transplants annually, including peripheral blood and bone marrow transplants.
• Photodynamic Therapy (PDT): Photodynamic therapy is an innovative treatment that combines visible light with a photosensitizing agent selectively absorbed by diseased tissue. Activation of the photosensitizer leads to targeted destruction of abnormal cells while sparing surrounding healthy tissue, making PDT a precise and organ-preserving therapeutic option.
• Dendritic Cell–Based Tumor Immunotherapy: University Hospital Duesseldorf utilizes dendritic cell–based immunotherapy to stimulate the patient’s immune system against cancer. Tumor antigens are loaded onto dendritic cells ex vivo and reintroduced into the patient to activate cytotoxic T cells, enabling targeted recognition and destruction of tumor cells.
• Mesenchymal Stem Cell Research & Therapy: The hospital conducts advanced research into mesenchymal stem cells (MSCs) and their regenerative and immunomodulatory roles. These cells are investigated for tissue repair, immune regulation, and innovative therapeutic strategies, including targeted cellular delivery systems in oncology and regenerative medicine.
• Regional Deep Hyperthermia: Regional deep hyperthermia is used for therapy-resistant, recurrent, or unresectable solid tumors. Tumor tissue is selectively heated to 42–44°C, disrupting tumor metabolism, inducing apoptosis, and enhancing immune recognition.
  When combined with chemotherapy or radiotherapy, hyperthermia can improve treatment response, enhance local tumor control, and help avoid extensive surgical procedures.

Why Patients Choose University Hospital Duesseldorf

• Academic excellence: Direct integration of care with university research and innovation
• Highly specialized expertise: Access to internationally experienced specialists
• Advanced technology: Continuous use of cutting-edge medical systems
• Multidisciplinary care: Coordinated treatment for complex conditions

Ideal for Medical Tourism via GS Medical Services

• Central location in western Germany with excellent international connectivity
• GS Medical Services provides end-to-end support, including appointment coordination, specialist consultations, treatment planning, travel arrangements, accommodation, and multilingual assistance